PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Haemostaseology and Hemophilia Center, Medical Clinic 2, Institute of Transfusion Medicine, University Hospital Frankfurt, Germany.\', \'Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, United Kingdom.\', \'Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1177/1076029620938149
?:hasPublicationType
?:journal
  • Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
is ?:pmid of
?:pmid
?:pmid
  • 32677459
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
?:type

Metadata

Anon_0  
expand all